401 related articles for article (PubMed ID: 22840417)
1. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.
Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417
[TBL] [Abstract][Full Text] [Related]
2. Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents.
Husain A; Rashid M; Shaharyar M; Siddiqui AA; Mishra R
Eur J Med Chem; 2013 Apr; 62():785-98. PubMed ID: 23333063
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of benzimidazoles bearing oxadiazole nucleus as anticancer agents.
Rashid M; Husain A; Mishra R
Eur J Med Chem; 2012 Aug; 54():855-66. PubMed ID: 22608854
[TBL] [Abstract][Full Text] [Related]
4. 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents.
Noolvi MN; Patel HM; Kamboj S; Kaur A; Mann V
Eur J Med Chem; 2012 Oct; 56():56-69. PubMed ID: 22960694
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents.
Ibrahim DA
Eur J Med Chem; 2009 Jul; 44(7):2776-81. PubMed ID: 19203813
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer evaluation of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles, 1,2,4-triazoles and Mannich bases.
Megally Abdo NY; Kamel MM
Chem Pharm Bull (Tokyo); 2015; 63(5):369-76. PubMed ID: 25948330
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles.
Kumar D; Kumar NM; Chang KH; Gupta R; Shah K
Bioorg Med Chem Lett; 2011 Oct; 21(19):5897-900. PubMed ID: 21873049
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents.
Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X
Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694
[TBL] [Abstract][Full Text] [Related]
11. In-vitro anti-HIV and antitumor activity of new 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and thiadiazine analogues.
Al-Soud YA; Al-Masoudi NA; Loddo R; La Colla P
Arch Pharm (Weinheim); 2008 Jun; 341(6):365-9. PubMed ID: 18493972
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives bearing 3,4,5-trimethoxyphenyl moiety.
Zhao PL; Duan AN; Zou M; Yang HK; You WW; Wu SG
Bioorg Med Chem Lett; 2012 Jul; 22(13):4471-4. PubMed ID: 22647723
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new Tetra-aza macrocyclic scaffold constrained oxadiazole, thiadiazole and triazole rings.
Vinay Kumar B; Naik HS; Girija D; Sharath N; Sudeep HV; Joy Hoskeri H
Arch Pharm (Weinheim); 2012 Mar; 345(3):240-9. PubMed ID: 22147500
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
Özdemir A; Sever B; Altıntop MD; Temel HE; Atlı Ö; Baysal M; Demirci F
Molecules; 2017 Jul; 22(7):. PubMed ID: 28677624
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of some novel bis-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and bis-4-thiazolidinone derivatives from terephthalic dihydrazide.
Palekar VS; Damle AJ; Shukla SR
Eur J Med Chem; 2009 Dec; 44(12):5112-6. PubMed ID: 19683841
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety.
Bhat KS; Poojary B; Prasad DJ; Naik P; Holla BS
Eur J Med Chem; 2009 Dec; 44(12):5066-70. PubMed ID: 19822384
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.
Kamel MM; Megally Abdo NY
Eur J Med Chem; 2014 Oct; 86():75-80. PubMed ID: 25147148
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new chiral 2,5-disubstituted 1,3,4-thiadiazoles possessing gamma-butenolide moiety and preliminary evaluation of in vitro anticancer activity.
Wei MX; Feng L; Li XQ; Zhou XZ; Shao ZH
Eur J Med Chem; 2009 Aug; 44(8):3340-4. PubMed ID: 19371980
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and bioassay of a new class of heterocycles pyrrolyl oxadiazoles/thiadiazoles/triazoles.
Padmavathi V; Nagendra Mohan AV; Thriveni P; Shazia A
Eur J Med Chem; 2009 May; 44(5):2313-21. PubMed ID: 18547683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
